Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003653 |
---|---|
Receipt number | R000004426 |
Scientific Title | Phase II study of S-1 plus amrubicin as the 2nd-line treatment for non-small cell lung cancer without EGFR mutation |
Date of disclosure of the study information | 2010/05/25 |
Last modified on | 2017/07/11 09:31:53 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/24 08:42:22 | ||
2 | Update | 2010/11/30 18:00:11 | Name of person sending information Organization Division name Address |
|
3 | Update | 2011/05/24 09:58:53 | Recruitment status |
|
4 | Update | 2013/11/18 12:48:45 | TEL Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
5 | Update | 2013/11/18 12:49:19 | Recruitment status Publication of results |
|
6 | Update | 2017/07/11 09:31:53 | Name of primary person or sponsor Organization |